Functional Recovery in Critically Ill Children
1 other identifier
observational
30
1 country
1
Brief Summary
Intensive Care Unit-acquired weakness (ICU-AW) is a well-recognized, important and preventable sequelae of critical illness, affecting up to 60% of adult ICU patient. ICU-AW is associated with increased mortality and length of stay, and negatively impacts long-term functional outcomes and quality of life in affected patients and their caregivers. While delayed mobilization adversely affects clinical outcomes, early rehabilitation in the critically ill adult population is safe, feasible, cost effective, results in more ventilator free-days and better functional outcomes at hospital discharge. In contrast, there is a paucity of this research in pediatrics. Our research suggests that immobilization is common in critically ill children, and rehabilitation is delayed particularly in the sickest children who are arguably at highest risk of morbidity. It is unclear however, whether delayed rehabilitation leads to adverse outcomes in critically ill children, as has been demonstrated in adults. Our objectives of this study are to evaluate if immobilization and delayed rehabilitation negatively impacts short-term clinical outcomes and the time to functional recovery in critically ill children. The investigators hypothesize that the following factors may influence functional recovery and morbidity in critically ill children:
- Pre-morbid condition
- Age
- Time-to-initiation of acute rehabilitation
- Critical illness disease severity
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 30, 2012
CompletedFirst Posted
Study publicly available on registry
November 12, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedNovember 5, 2013
November 1, 2013
1.1 years
October 30, 2012
November 3, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility
Feasibility will be determined by the consent and enrolment rate, and the protocol adherence and follow-up rates.
12 months
Secondary Outcomes (4)
Functional Recovery
Baseline, 3 and 6 month follow-up
Pediatric Critical care Unit (PCCU) clinical outcomes
at 30 days and duration of hospitalization
Muscle Strength
Hospital discharge and at 3 and 6 month follow-up
Parental or caregiver stress
3 month follow-up
Other Outcomes (1)
Feasibility and reliability of screening for PCCU-acquired weakness
Duration of Hospitalization, 3 and 6 months follow-up
Study Arms (1)
Observational Cohort
No Intervention
Eligibility Criteria
Critically Ill Children
You may qualify if:
- Age over 12 months to 17 years
- PCCU stay of ≥ 48 hours
- Patient is limited to bed-rest and has not been mobilized during the first 48 hours of PCCU admission
- Equal to or greater than one organ dysfunction on PCCU admission (as measured by PELOD)
- Informed consent of patient/substitute decision maker.
You may not qualify if:
- Age: \< 12 months or ≥18 years
- Patients admitted to step-down/intermediate care
- Patients transferred from Neonatal intensive care unit and never discharge home.
- iv) Patients who are already mobilizing well, or are at baseline functional status at time of screening v) Admission diagnosis of a neuromuscular disorder: e.g. Acute Guillain-Barré Syndrome, Botulism, Myasthenia Gravis), or acute spinal cord injury/transverse myelitis vi) Not expected to survive PCCU/hospital stay vii) Previously enrolled into study less than 6 months ago and/or still undergoing study procedures at time of screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karen Choonglead
Study Sites (1)
McMaster Children's Hospital
Hamilton, Ontario, L8N 3Z5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen Choong, MB, BCh, MSc
McMaster University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
October 30, 2012
First Posted
November 12, 2012
Study Start
October 1, 2012
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
November 5, 2013
Record last verified: 2013-11